Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.

Ogawa, Setsuro; Arakawa, Akio; Hayakawa, Kazuhiro; Yoshiyama, Tamotsu

Ogawa, Setsuro; Arakawa, Akio; Hayakawa, Kazuhiro; Yoshiyama, Tamotsu.

Affiliation

Ogawa S; Department of Anesthesiology, Nihon University School of Medicine/Surugadai Nihon University Hospital, Tokyo, Japan.
Arakawa A; Portfolio and Project Management, Pfizer Japan Inc., Tokyo, Japan.
Hayakawa K; Medical Affairs, Pfizer Japan Inc., Tokyo, Japan.
Yoshiyama T; Clinical Statistics, Pfizer Japan Inc., 3-22-7 Yoyogi, Shibuya-ku, Tokyo, 151-8589, Japan. tamotsu.yoshiyama@pfizer.com.

Clin Drug Investig ; 36(11): 877-888, 2016 Nov.

Article in En | MEDLINE | ID: mdl-27448285

Subject(s)

Diabetic Neuropathies/drug therapy; Neuralgia, Postherpetic/drug therapy; Neuralgia/drug therapy; Pregabalin/therapeutic use; Adult; Aged; Aged, 80 and over; Analgesics/administration & dosage; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain Measurement; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Young Adult

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Diabetic Neuropathies / Neuralgia, Postherpetic / Pregabalin / Neuralgia Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Drug Investig Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: Japan Country of publication: New Zealand

Search on Google

Add to My VHL

XML

PubMed Links